|
|
|
|
| LEADER |
00000nam a22000003a 4500 |
| 001 |
8384208 |
| 003 |
ICU |
| 005 |
20110706085100.0 |
| 006 |
m||||||||d|||||||| |
| 007 |
cr||n||||||||| |
| 008 |
070809s2007 enka ob 001 0 eng d |
| 020 |
|
|
|a 9780470093146 (electronic bk.)
|
| 020 |
|
|
|a 0470093145 (electronic bk.)
|
| 020 |
|
|
|z 9780470851715
|
| 020 |
|
|
|a 6610855005 (electronic bk.)
|
| 020 |
|
|
|a 9786610855001 (electronic bk.)
|
| 020 |
|
|
|z 0470093137 (Cloth)
|
| 035 |
|
|
|a ybp2939262
|
| 037 |
|
|
|b OverDrive, Inc.
|n http://www.overdrive.com
|
| 040 |
|
|
|a NhCcYBP
|c NhCcYBP
|
| 050 |
|
4 |
|a RM301.25
|b .P75 2007
|
| 060 |
|
4 |
|a 2007 F-613
|
| 060 |
|
4 |
|a QV 736
|b P9567 2007
|
| 072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615/.19
|2 22
|
| 245 |
0 |
0 |
|a Principles and practice of pharmaceutical medicine /
|c edited by Lionel D. Edwards ... [et al.].
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Chichester, West Sussex ;
|a Hoboken, NJ :
|b John Wiley & Sons,
|c c2007.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/c
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/cr
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Cover -- Contents -- Preface to the First Edition -- Preface to the Second Edition -- About the Editors -- Contributors -- SECTION I: OVERVIEW OF PHARMACEUTICAL MEDICINE -- 1 The Practice and Practitioners of Pharmaceutical Medicine -- 2 Pharmaceutical Medicine as a Medical Specialty -- 3 Clinical Research Education and Training for Biopharmaceutical Staff -- SECTION II: DRUG DISCOVERY AND DEVELOPMENT -- Introduction -- 4 Drug Discovery: Design and Serendipity -- 5 Pharmaceutics -- 6 Nonclinical Toxicology -- 7 Informed Consent -- 8 Phase I: The First Opportunity for Extrapolation from Animal Data to Human Exposure -- 9 Phase II and Phase III Clinical Studies -- 10 Phase IV Drug Development: Post-Marketing Studies -- 11 Site Management -- 12 Good Clinical Practices -- 13 Quality Assurance, Quality Control and Audit -- 14 The Unique Role of Over-the-Counter Medicine -- SECTION III: SPECIAL POPULATIONS AND REQUIRED SPECIAL STUDIES -- Introduction -- 15 Drug Research in Older Patients -- 16 Drug Development Research in Women -- 17 Clinical Research in Children -- 18 Racial and Ethnic Issues in Drug Registration -- 19 Hepatic and Renal Failure -- 20 Drug Interactions -- 21 Orphan Drugs -- SECTION IV: APPLIED ASPECTS OF DRUG DEVELOPMENT -- Introduction -- 22 Biotechnology Products and Development -- 23 Pharmacoeconomics: Economic and Humanistic Outcomes -- 24 Pharmacoepidemiology and the Pharmaceutical Physician -- 25 Statistical Principles and Application in Biopharmaceutical Research -- 26 Data Management -- 27 Patient Compliance: Pharmionics, a New Discipline -- 28 Monitoring Drug Concentrations in Clinical Practice -- 29 Generics -- 30 Complementary Medicines -- SECTION V: DRUG REGULATION -- Introduction -- 31 United States Regulations -- 32 Special US Regulatory Procedures: Emergency and Compassionate INDs and Accelerated Product Approvals -- 33 The Development of Human Medicines Control in Europe from Classical Times to the Year 2000 -- 34 Medicines Regulation in the European Union -- 35 Japanese Regulations -- 36 Drug Registration and Pricing in the Middle East -- SECTION VI: MEDICAL SERVICES -- Introduction -- 37 Medical Affairs -- 38 Drug Labeling -- 39 Drug Surveillance -- 40 Data Mining -- 41 Risk Management in Product Approval and Marketing -- 42 Publishing Clinical Studies -- 43 Organizing and Planning Local, Regional, National and International Meetings and Conferences -- 44 Drug Withdrawals from the Market -- Causes and Consequences -- SECTION VII: LEGAL AND ETHICAL ASPECTS OF PHARMACEUTICAL MEDICINE -- Introduction -- 45 Introduction to Bioethics for Pharmaceutical Professionals -- 46 Pharmaceutical Medicine and the Law -- 47 Pharmaceutical Product Liability -- 48 Patents -- 49 Fraud and Misconduct in Clinical Research -- SECTION VIII: BUSINESS ASPECTS -- Introduction -- 50 The Multinational Corporations: Cultural Challenges, the Legal/Regulatory Framework and the Medico.
|
| 588 |
|
|
|a Description based on print version record.
|
| 650 |
|
0 |
|a Drug development.
|0 http://id.loc.gov/authorities/subjects/sh97007921
|
| 650 |
|
0 |
|a Drugs
|x Research.
|0 http://id.loc.gov/authorities/subjects/sh85039745
|
| 650 |
|
0 |
|a Pharmacology.
|0 http://id.loc.gov/authorities/subjects/sh85100599
|
| 650 |
1 |
2 |
|a Drug Evaluation.
|
| 650 |
1 |
2 |
|a Drug Industry
|x organization and administration.
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 http://id.worldcat.org/fast/fst00898670
|
| 650 |
|
7 |
|a Drugs
|x Research.
|2 fast
|0 http://id.worldcat.org/fast/fst00898894
|
| 650 |
|
7 |
|a Pharmacology.
|2 fast
|0 http://id.worldcat.org/fast/fst01060259
|
| 700 |
1 |
|
|a Edwards, Lionel D.
|0 http://id.loc.gov/authorities/names/n2007181249
|1 http://viaf.org/viaf/166059581
|
| 776 |
0 |
8 |
|i Print version:
|t Principles and practice of pharmaceutical medicine.
|b 2nd ed.
|d Chichester, West Sussex ; Hoboken, NJ : John Wiley & Sons, c2007
|z 9780470093139
|z 0470093137
|w (DLC) 2007011029
|
| 856 |
4 |
0 |
|u http://onlinelibrary.wiley.com/book/10.1002/9780470093153
|
| 901 |
|
|
|a YBPebook
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)163575883
|
| 929 |
|
|
|a eresource
|
| 999 |
f |
f |
|i 42cbdb7f-9cb2-524b-938c-680e0002ea3b
|s 7153b5cf-87dc-5a48-9a06-080431daa686
|
| 928 |
|
|
|t Library of Congress classification
|a RM301.25 .P75 2007
|l Online
|c UC-FullText
|u http://onlinelibrary.wiley.com/book/10.1002/9780470093153
|g ebooks
|e BILL
|i 8152609
|
